Risk of SARS-CoV-2 reinfection and COVID-19 hospitalisation in individuals with natural and hybrid immunity: a retrospective, total population cohort study in Sweden

P Nordström, M Ballin, A Nordström - The Lancet Infectious Diseases, 2022 - thelancet.com
Background Real-world evidence supporting vaccination against COVID-19 in individuals
who have recovered from a previous SARS-CoV-2 infection is sparse. We aimed to …

Risk of SARS-CoV-2 reinfection and COVID-19 hospitalisation in individuals with natural and hybrid immunity: a retrospective, total population cohort study in Sweden

P Nordström, M Ballin, A Nordström - The Lancet Infectious Diseases, 2022 - Elsevier
Background Real-world evidence supporting vaccination against COVID-19 in individuals
who have recovered from a previous SARS-CoV-2 infection is sparse. We aimed to …

Risk of SARS-CoV-2 reinfection and COVID-19 hospitalisation in individuals with natural and hybrid immunity: a retrospective, total population cohort study in Sweden.

P Nordström, M Ballin, A Nordström - The Lancet. Infectious …, 2022 - europepmc.org
Background Real-world evidence supporting vaccination against COVID-19 in individuals
who have recovered from a previous SARS-CoV-2 infection is sparse. We aimed to …

[HTML][HTML] Risk of SARS-CoV-2 reinfection and COVID-19 hospitalisation in individuals with natural and hybrid immunity: a retrospective, total population cohort study in …

P Nordström, M Ballin, A Nordström - The Lancet Infectious Diseases, 2022 - thelancet.com
Background Real-world evidence supporting vaccination against COVID-19 in individuals
who have recovered from a previous SARS-CoV-2 infection is sparse. We aimed to …

Risk of SARS-CoV-2 Reinfection and COVID-19 Hospitalisation in Individuals With Natural-and Hybrid Immunity: A Retrospective, Total Population Cohort Study in …

P Nordström, M Ballin, A Nordström - Total Population Cohort Study in … - papers.ssrn.com
Background: Real-world evidence supporting Coronavirus disease 2019 (Covid-19)
vaccination in individuals who have recovered from a previous infection is lacking. Methods …

Risk of SARS-CoV-2 reinfection and COVID-19 hospitalisation in individuals with natural and hybrid immunity: a retrospective, total population cohort study in Sweden.

P Nordström, M Ballin, A Nordström - 2022 - cabidigitallibrary.org
Background: Real-world evidence supporting vaccination against COVID-19 in individuals
who have recovered from a previous SARS-CoV-2 infection is sparse. We aimed to …

[HTML][HTML] Risk of SARS-CoV-2 reinfection and COVID-19 hospitalisation in individuals with natural and hybrid immunity: a retrospective, total population cohort study in …

P Nordström, M Ballin, A Nordström - Lancet. Infectious diseases …, 2022 - diva-portal.org
BACKGROUND: Real-world evidence supporting vaccination against COVID-19 in
individuals who have recovered from a previous SARS-CoV-2 infection is sparse. We aimed …

Risk of SARS-CoV-2 reinfection and COVID-19 hospitalisation in individuals with natural and hybrid immunity: a retrospective, total population cohort study in Sweden

P Nordström, M Ballin… - The Lancet. Infectious …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Real-world evidence supporting vaccination against COVID-19 in individuals
who have recovered from a previous SARS-CoV-2 infection is sparse. We aimed to …

[HTML][HTML] Risk of SARS-CoV-2 reinfection and COVID-19 hospitalisation in individuals with natural and hybrid immunity: a retrospective, total population cohort study in …

P Nordström, M Ballin, A Nordström - The Lancet. Infectious …, 2022 - ncbi.nlm.nih.gov
Background Real-world evidence supporting vaccination against COVID-19 in individuals
who have recovered from a previous SARS-CoV-2 infection is sparse. We aimed to …

Risk of SARS-CoV-2 reinfection and COVID-19 hospitalisation in individuals with natural and hybrid immunity: a retrospective, total population cohort study in Sweden.

P Nordström, M Ballin, A Nordström - The Lancet. Infectious …, 2022 - europepmc.org
Background Real-world evidence supporting vaccination against COVID-19 in individuals
who have recovered from a previous SARS-CoV-2 infection is sparse. We aimed to …